CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) will present 23 company-sponsored platform and poster presentations at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, taking place in Toronto, Canada, June 20-25. The data to be presented underscore the company’s ongoing commitment to hemophilia through continued research with its available therapies and early-stage programs.
Help employers find you! Check out all the jobs and post your resume.
